or Try an Advanced Search...

    Type II Diabetes Stocks List

    Symbol Grade Name % Change
    NBIX C Neurocrine Biosciences, Inc. 1.61
    ALKS F Alkermes plc 3.00
    NMRD F Nemaura Medical Inc. -99.38
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Diabetes Type I Diabetes Alcohol Pain Schizophrenia Angina Atypical Antipsychotics Biopharmaceutical Blood Glucose Monitoring Blood Sugar Level Blood Test Cachexia Cardiovascular Disease Chemotherapy Cholesterol Clinical Development Cocaine Constipation Continuous Glucose Monitor Depressive Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Type II Diabetes stocks.

    Symbol Grade Name Weight
    IBRN B iShares Neuroscience and Healthcare ETF 7.06
    FBT A First Trust Amex Biotech Index Fund 6.59
    MNTL D Tema Neuroscience and Mental Health ETF 5.16
    PSIL B AdvisorShares Psychedelics ETF 4.61
    PBE C PowerShares Dynamic Biotech & Genome 4.0
    View all Type II Diabetes ETFs...
    Compare ETFs
    Compare FBT to MNTL Compare MNTL to PBE Compare PSIL to PBE

        Type II Diabetes Stocks Recent News

        Date Stock Title
        Oct 31 NBIX Neurocrine Biosciences Inc (NBIX) Q3 2024 Earnings Call Highlights: Strong Sales and Strategic ...
        Oct 31 NBIX Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
        Oct 30 NBIX Neurocrine Biosciences, Inc. (NBIX) Q3 2024 Earnings Call Transcript
        Oct 30 NBIX Neurocrine stock jumps 9% on strong Ingrezza sales, stock buyback
        Oct 30 NBIX Neurocrine (NBIX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
        Oct 30 NBIX Neurocrine Biosciences, Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 30 NBIX Neurocrine Biosciences (NBIX) Q3 Earnings Miss Estimates
        Oct 30 NBIX Neurocrine: Q3 Earnings Snapshot
        Oct 30 NBIX Neurocrine Biosciences bats Q3 revenue estimates, revises guidance
        Oct 30 NBIX Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance
        Oct 29 NBIX Neurocrine Biosciences Q3 2024 Earnings Preview
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Diabetes Type I Diabetes Alcohol Pain Schizophrenia Angina Atypical Antipsychotics Biopharmaceutical Blood Glucose Monitoring Blood Sugar Level Blood Test Cachexia Cardiovascular Disease Chemotherapy Cholesterol Clinical Development Cocaine Constipation Continuous Glucose Monitor Depressive Disorder
        Type II Diabetes

        Type 2 diabetes is a chronic condition that affects the way the body processes blood sugar (glucose). It is the most common form of diabetes, and it occurs when the body does not produce enough insulin or does not use insulin properly. People with type 2 diabetes may need to take medication or make lifestyle changes to manage their condition.

        Browse All Tags